Workflow
贝瑞基因: 关于控股股东及其一致行动人权益变动触及1%整数倍的公告

Summary of Key Points Core Viewpoint - The announcement details a significant change in shareholding for Chengdu Berry Genomics Co., Ltd. due to stock pledge defaults by a major shareholder, resulting in forced sales of shares through judicial auction [1]. Group 1: Shareholding Changes - The controlling shareholder, Gao Yang, had 157,230 shares sold, representing 0.04% of the total share capital, due to a stock pledge default [1]. - A total of 13,785,075 shares held by the associated party, Hou Ying, were auctioned, with 8,656,886 shares transferred on July 21, 2025, accounting for 2.45% of the total share capital [1]. - The total shares reduced by both Gao Yang and Hou Ying amounted to 8,814,116 shares, which is 2.49% of the total share capital [1]. Group 2: Shareholding Structure Post-Change - After the changes, the total shares held by the company decreased from 42,395,815 shares (11.99%) to 33,581,699 shares (9.50%) [2]. - The number of unrestricted shares held dropped from 18,404,273 shares (5.21%) to 9,590,157 shares (2.71%), while the restricted shares remained unchanged at 23,991,542 shares (6.79%) [2]. - The company confirmed that the judicial enforcement and auction did not adversely affect its operational or financial status, nor its governance structure [2].